Frontlight ResearchEarly access
Migraine trials in Argentina
5 of 6 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleA Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
- Where
- Buenos Aires, Córdoba, Mar del Plata, Río Cuarto, Rosario, San Miguel de Tucumán
- Age
- 12 years to 17 years
- People
- 285 worldwide
- Run by
- H. Lundbeck A/S
See details and how to joinNCT04965675 · EU 2024-510656-13-00 - Phase 3Taking peopleA Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
- Where
- Buenos Aires, Córdoba, Mar del Plata, Río Cuarto, Rosario, San Miguel de Tucumán
- Age
- 6 years to 17 years
- People
- 600 worldwide
- Run by
- H. Lundbeck A/S
See details and how to joinNCT05164172 · EU 2022-502917-27-00 - Phase 3Taking peopleA Study of Eptinezumab in Pediatric Participants With Episodic Migraine
- Where
- Buenos Aires, Córdoba, Río Cuarto, Rosario, San Miguel de Tucumán
- Age
- 6 years to 17 years
- People
- 315 worldwide
- Run by
- H. Lundbeck A/S
See details and how to joinNCT05897320 · EU 2022-502538-14-00 - Phase 3Taking peopleA Study to Learn About the Study Medicine Called Rimegepant in Women When Used for Intermittent Prevention of Menstrual Migraine
- Where
- Buenos Aires, CABA, Córdoba, Cordoba Capital, San Miguel de Tucumán
- Age
- 18 years to 45 years
- People
- 723 worldwide
- Run by
- Pfizer
See details and how to joinNCT06641466 · EU 2024-517121-10-00 - No phaseTaking peopleCarotid Sinus Massage in Trendelenburg Position for Headache Relief
- Where
- Trenque Lauquen
- Age
- 16 years and over
- People
- 18
- Run by
- Hospital Municipal Pedro T. Orellana
See details and how to joinNCT06745648